Glaucoma Genetics – Regulation of Cell Surviving and Death in the Retina by Maria D. Pinazo-Durán et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
9 
Glaucoma Genetics – Regulation of  
Cell Surviving and Death in the Retina 
Maria D. Pinazo-Durán1, Roberto Gallego-Pinazo2,  
Vicente Zanón-Moreno3,4, and Manuel Serrano5 
1Ophthalmic Research Unit “Santiago Grisolia”, Valencia, 
2Ophthalmology Department, University and Polytechnic Hospital La Fé, Valencia, 
3Preventive Medicine and Public Health Department.  
Medical School, University of Valencia, 
4CiberOBN - Biomedical Research Center Network of  
Pathophysiology of Obesity and Nutrition, 
5Spanish National Cancer Research Center (CNIO), Madrid, 
Spain 
 
1. Introduction 
Primary open-angle glaucoma (POAG) is a leading cause of various degrees of visual 
impairment and blindness worldwide, affecting in a disproportional manner women 
Afroamericans and Asians. In the Canadian Glaucoma Study, a recent multicenter 
prospective longitudinal study carried out in 258 participants (131 men versus 127 women; 
median age, 65.0 years), patients were followed up at 4-month intervals with perimetry, 
optic disc imaging, and a standardized interventional protocol for intraocular pressure (IOP) 
control. Univariate and proportional hazards models were used by the authors, in order to 
identify factors that predicted glaucoma progression. Data from this study showed that 
higher baseline age (HR per year, 1.04; 95% CI, 1.01-1.07), female sex (HR, 1.94; 95% CI, 1.09-
3.46), and higher mean follow-up IOP (HR per 1 mm Hg, 1.19; 95% CI, 1.05-1.36) were 
associated with progression of glaucomatous disease (Chauhan et al., 2008). 
It was estimated that over 8.4 million people were bilaterally blind from glaucoma in 2010, 
rising to 11.1 million by 2020. (Quigley & Broman, 2006). Moreover, approximately 50% of 
patients with POAG remain undiagnosed in most communities. 
A wide spectrum of etiopathogenic theories have been proposed in relation to glaucoma. In 
the 19th century, Müller described that the elevated IOP caused a compression in the eye 
tissues, whereas chronic heightened IOP led subsequently to the neuronal death (elder 
mechanical theory), while simultaneously von Jaeger (1858) suggested that vascular 
alterations were responsible of the optic atrophy (vascular theory). Schnabel (1892) reported 
that it were created empty spaces during the process of atrophy of neural elements, which 
bowing back of the lamina cribrosa and posteriorly cupping the nervehead (cavernous 
atrophy theory). In 1925, La Grange and Beauvieux established that glaucomatous optic 
neuropathy was secondary to ischaemia (ischaemic theory). Changing criteria in the seventies 
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pointed to the role of altered axoplasmic flow in glaucomatous optic neuropathy. In fact, 
monkey eyes with a lesser elevation of IOP and shorter duration of glaucoma, showed 
changes sharply localized to the axon bundles in the scleral lamina cribrosa. Accumulation 
of mitochondria was detected anterior and posterior to collagenous septae. These changes 
co-localized to the sites of axoplasmic transport blockage, as identified by autoradiographic 
studies. It was speculated that these cytologic changes reflect interruption of axoplasmic 
flow in the optic nerve of glaucoma eyes, which raised the new mechanical theory 
(Gasterlaand et al., 1978).  
The resistance of the trabecular meshwork (TM) to aqueous humour outflow increases as an 
ageing change, leading to increased IOP (Levin 1997). Therefore, elevated IOP is considered 
the main factor responsible for the glaucomatous optic neuropathy, this latter involving 
death of retinal ganglion cells and their axons. Clinically it is characterized by 
morphologic/morphometric changes of the optic disc, visual field defects (Agarwal et al., 
2002) and increased rate of retinal nerve fiber layer thinning (Lee et al., 2011).  
New extensive investigations into glaucoma pathophysiology contribute to our 
understanding of the role of a high variety of factors in the retinal ganglion cells damage 
and death. External and internal factors, as those within the retina and optic nerve 
ultrastructure, are important in the development and progression of primary open-angle 
glaucoma (POAG) (Lutjen-Drecoll et al., 1986; Hernandez et al., 1991; Triviño et al., 1996). 
More recent scientific knowledge revealed a complex situation in which other factors, as the 
circulatory (Yanagi et al., 2010), inflammatory (Kumarasamy et al., 2006), toxicologic (Schori 
et al., 2001), biochemical and molecular (Zanón-Moreno & Pinazo-Durán, 2008; Zanón-
Moreno et al., 2008, 2009; Ray & Mookherjee, 2009, Osborne, 2010), are likely to be involved 
in the pathogenesis of glaucomatous optic neuropathy.  
Whatever may be the real factors involved in glaucoma pathogenesis, the glaucomatous 
eyes suffer the dysfunction and death of the retinal ganglion cells leading to optic atrophy 
and irreversible visual loss. This may be the consequence of the association of multiple 
factors rather than only one functioning individually. In this context one question arises as 
to whether the molecular and cellular POAG basis, can be closely related to cell cycle 
abnormalities, leading to cell surviving and death involutionary processes, as a response to 
a cell stressor: the increased IOP.  
1.1 The cell cycle 
The cell-division cycle, are recognized as the events occurring in a cell that leads to its 
division and duplication (replication). The cell cycle consists of four phases: Gap 1 (G1) 
phase is the interval between mitosis and DNA synthesis, DNA synthesis (S) phase, Gap 2 
(G2) phase (interphase) during which growth and preparation for cell division occurs, and 
finally the mitosis and cytokinesis (M) phase, as shown in the Fig. 1. During the cell cycle 
progression, activation of each phase is strictly dependent on the proper completion of the 
previous one. It has also to be stated that the cells that have temporarily stopped dividing 
have entered a stage of quiescence named the G0 phase. 
Cell cycle is positively regulated by holoenzymes formed by a regulating subunit called 
cyclin (cyc), and cyclin-dependent kinases (cdk) (Ivanova et al., 2011). These complexes 
cyc/cdk become activated or inhibited sequentially in different phases of the cell cycle. Cell 
cycle progression is the result of the interaction between cyclins and their cdks, and a high 
variety of inhibitory proteins, the corresponding cdk inhibitors (cdki) (Lee et al., 2005). As 
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Fig. 1. The cell-division phases 
shown in the following scheme, the cycD and the corresponding cdk4/6 activities regulate 
the early progression of the cell cycle, through the G1 phase. Then, cycE can be expressed, 
and in association with cdk2 controls the G1-S transition step. Finally, cell cycle arrest is 
achieved by the negative regulation of cdks, exerted either by antiproliferative signals or by 
the specific cdki activities (Serrano et al., 1993) (Fig. 2). Following growth arrest cells undergo 
senescence or apoptosis (Chen et al., 2000). The cip/kip family of cdki includes the genes 
p21CIP1/WAF (p21), p27 and p57, which halt cell cycle in G1 phase and inhibit several 
cyc/ckd complexes. The Inhibitor of Kinase 4/Alternative Reading Frame (INK4a/ARF) 
family prevent the progression of the cell cycle, and includes p16INK4a (p16), p15, p18, and 
p19, which specifically inhibit ccyc/dk4/6 activities (Serrano et al., 1993; Dean et al., 2010). 
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Fig. 2. 
1.2 Genetics of glaucoma  
Glaucoma is a multifactorial disease in which genetic and environmental factors are 
involved. Advancing knowledge in glaucoma is slow and insidious, because the polygenic 
character of the disease makes more difficult to progress through the genetic studies. 
However, genetics of glaucoma are the key for get preventing the glaucomatous blindness. 
It is necessary to deepen inside the influence of polymorphisms of each gene with the 
disease and, likewise, analyze the interactions among these genes (gene-gene) and through 
them with the environment (gene-environment).  
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Currently, there are some genes which have been associated to glaucoma, as 
myocilin/trabecular meshwork inducible glucocorticoid response (MYOC/TIGR) gene, that 
was identified in the latter nineties (Stone et al., 1997). The MYOC gene encodes an 
extracellular glycoprotein called myocilin. This protein is expressed in different human 
organs, among them the TM, ciliary body, retina and optic nervehead. Mutations in this 
gene result in juvenile glaucoma. The MYOC gene is altered in approximately 4% of cases of 
POAG (Lopez-Martinez et al., 2007). 
Subsequently, other genes related to glaucoma were identified. Another causative gene was 
localized on chromosome 10p14 in a study of 54 families with autosomal dominantly 
inherited adult-onset POAG. It was designated OPTN (by its related protein, optineurin). 
The OPTN gene codes for a conserved 66-kilodalton protein of unknown function that has 
been implicated in the tumor necrosis factor-alpha signaling pathway and that interacts 
with diverse proteins including Huntingtin, Ras-associated protein RAB8, and transcription 
factor IIIA. Optineurin is expressed in the TM, nonpigmented ciliary epithelium, retina, and 
brain, and it was speculated that it plays a neuroprotective role (Rezaie et al., 2002). 
Moreover, sequence alterations in OPTN were found in 16.7% of families with hereditary 
POAG, including individuals with normal intraocular pressure 
The WD repeat domain 36 (WDR36) gene that encodes a member of the WDR protein 
family was also found to be associated with glaucoma disease. WDR36 gene expressed in 
lens, iris, sclera, ciliary muscles, ciliary body, TM, retina and optic nerve, as established by 
real time-PCR. WDR36 is a novel causative gene for adult-onset POAG at the open-angle 
glaucoma (GLC1G) locus. Specific ocular expressions and observed mutations are consistent 
with WDR36 role in aetiology of both high- and low-pressure glaucoma (Monemi et al., 
2005). 
The CYP1B1 gene encodes a dioxin inducible member of subfamily I of the cytochrome 
p450 protein superfamily. The human CYP1B1 gene consists of three exons of which the first 
is non-coding. The putative open reading frame starts in the second exon and is 1629 bp in 
length, and the CYP1B1 gene has been related to 20-80% of primary congenital glaucoma 
cases (GLC3A) (Sitorus et al., 2003).  
In addition to these four genes (MYOC, OPTN WDR36, CYP1B1) alterations in many others 
and their possible association with some type of glaucoma have been analyzed. There are 
studies involving the apolipoprotein E (ApoE) gene polymorphisms in the glaucomatous 
optic neuropathy. Copin et al., (2002) indicate that single nucleotide polymorphisms on the 
promoter region of the ApoE gene is associated with increased optic nerve and visual field 
damage in glaucomatous patients. This study also demonstrates that another single 
nucleotide polymorphism interacts with the recently reported MYOC single nucleotide 
polymorphism (mt1) that, in turns results in increased IOP, suggesting that may be involved 
in the limited effectiveness of IOP-lowering treatments among POAG patients. More 
recently it has been shown that heterozygous non-synonymous variants of the retinitis 
pigmentosa GTPase regulator interacting protein 1 (RPGRIP1) gene also may cause, or 
increase, the susceptibility to various forms of glaucoma (Fernández-Martínez, 2011). 
At the same time, we shouldn't ignore epigenetics, which regards to the study of those 
heritable changes in phenotype or gene expression caused by processes different to variations 
in the DNA sequence. Epigenetic information modulates gene expression without alter the 
DNA sequence, by several mechanisms: 1) DNA methylation, 2) Genomic imprinting and  
3) Histone modifications –acetylation, methylation, phosphorylation-. Therefore, epigenetics 
does refer to the mechanisms that utilize the organism for translating the genetic 
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information of a generation. The clinical effects that arise from the disease-associated 
sequence changes in gene might be influenced by modifier genes, as well as by endogenous 
factors that could alter pathogenic mechanisms affected by the mutations. Therefore, it 
could potentially explain some variations in the observed clinical signs and symptoms and 
also in the progression rates of the POAG patients (Lam et al. 2000).  
Moreover, from a nutrition and health viewpoint, preventive strategies from population-
based recommendations to personalized nutritional advice are detected as an attractive 
topic. Biomedical studies may help in understanding how genetic variation and epigenetic 
events may change requirements and responses to nutrients, and developing outstanding 
techniques for identifying patients at risk because of its own nutrigenetic profile (Zeisel, 
2007). A discipline that is gaining importance in glaucoma studies is the nutritional genetics, 
which has two main branches: nutrigenetics and nutrigenomics. Nutrigenetics focuses on 
the study of genetic variations in the body's response to nutrients. Otherwise, nutrigenomics 
investigates the influence of nutrients on gene expression. In relation to these two concepts 
especial attention has to be paid to the emergence of nutrigenetic tests, which use genetic 
information to identify food products that suited or not suited to the personalized 
nutrigenetic profile, allowing us to define individual dietary advice (Haga et al, 2003). 
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Fig. 3. 
Numerous studies on gene alterations that encode proteins related to cell survival and death 
in relation to glaucoma have been conducted through the past twenty years, in order to stop 
or prevent apoptosis of retinal ganglion cells and optic nerve degeneration. In this regard, it 
has been analyzed mutations in genes of the B-cell lymphoma 2 (bcl-2) family such as the  
B-cell lymphoma 2-associated X (BAX) gene, which encodes a pro-apoptotic X protein. The 
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circuits involved in these cell pathways are shown below (Fig. 3). If the BAX protein is not 
present, or there are BAX limited availability, ganglion cell somas are capable to resist 
indefinitely an optic nerve insult. In the presence of BAX the damage cannot be blocked and 
cell death program reaches an irreversible point (Nickells, 2008).  
1.3 The p53 gene 
Another key protein in the regulation processes of cell survival and death is p53. It was 
identified in 1979 and encodes the transcription factor also named p53, a phosphoprotein 
(MW 53 kD). The p53 gene comprises 20 kb of DNA and is located on the short arm of 
chromosome 17p13.1 (Levine and Finlay 2004). It has been called the "guardian of the 
genome" (Lane 1992). Its expression and function has been related to apoptosis, cell 
proliferation and/or angiogenic processes.  
The p53 protein is located in the cytoplasm as an inactive monomer, but upon stimulation 
by a variety of cellular stresses, p53 forms a tetramer from double dimers. The p53 protein 
binds DNA (see the figure 4) and, among other target genes, induces the expression of the 
p21 gene to synthetize the p21 protein that, in turns, inhibits the cycE/cdk2 complexes. The 
complex p21/cycE/cdk2 inactivates cell division by stopping the cell cycle. p53 is an essential 
molecule in cell proliferation and apoptosis (Guevara et al., 1999). Inactive, as a good 
guardian, p53 only starts functioning when a genetic damage appears in a cell (Fig. 3,4). 
Only then, it activates a system with two main programs: 1) The cell suicide, 2) A process of 
cellular senescence by which the cell remains alive but unable to proliferate. The p53 gene 
detects almost any alteration in the cell, oncogenes and other DNA alterations, lack of 
nutrients, and abnormalities that occur during the proliferative and angiogenic processes. 
Therefore, p53 is a multifunctional “star” gene, involved in a wide spectrum of biomedical 
facts (Boesten et al., 2009; Gallego-Pinazo et al., 2008, 2010; Jeong et al., 2009). The tumour 
suppressor p53 mediates the cellular response to a variety of stresses mainly by regulating 
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the transcription of over 150 genes (Jeong et al, 2009). Active p53 gene can induce reversible 
growth arrest in the cell cycle G1 or G2 phases, as well as cellular senescence or apoptosis. 
As such, p53 acts as a sensor of damage to the genome (Lane 1992). Main biologic functions 
of p53 are shown in the scheme below. 
1.4 Glaucoma, visual loss and apoptosis 
In a first clinic-pathologic report Levin and Louhab (1996) identified retinal ganglion cells 
undergoing apoptosis in one of the eyes of a 70-year-old man with anterior ischaemic optic 
neuropathy. These authors speculated that the affected eye underwent a functional optic 
nerve axotomy. A wide variety of clinical and experimental studies strongly indicate that 
retinal ganglion cells and optic axons demise represents the final pathway of vision loss in 
glaucoma patients (Quigley et al., 2000; Agar et al., 2006; Ju et al., 2007; Agarwal et al., 2009, 
Lee et al., 2011) and that the intrinsic pathogenic mechanism is the ganglion cell death by 
apoptosis (Nickells 1999; Osborne et al., 1999; Osborne, 2011; Zhang & Bhavnani 2005; 
Levkovitch-Verbin 2009; Tatton, 2011). Although there are compelling evidences showing 
apoptosis as the primary and early mechanism of ganglion cell death in glaucoma 
(Levkovitch-Verbin 2006), necrosis is also a contributory mechanism in the late phase of 
glaucoma progression, evidence to which was observed in rats subjected to optic nerve 
transection (Cordeiro et al., 2010).  
When managing glaucoma patients, ophthalmologists consider individualized therapy for 
lowering IOP, as well as the true IOP-lowering efficacy of each drug that is given to any 
patient, and the compliance degree, with the final goal of maintaining the adequate IOP 
levels and subsequently the vision and the quality of life (Levin 1997; Agarwal et al., 2009). 
However, the anti-hypertensive therapy is clearly unable to properly maintain the visual 
function. Further research and translation of knowledge to the clinical practice in urgently 
needed to improve glaucoma prognosis. 
Apoptosis (Kerr et al., 1972) is a regulated manner to destroy a cell. During development 
apoptosis is a pivotal process. In addition, apoptosis performs essential functions in 
morphogenesis and tissue remodelling, homeostasis, removal of damaged or infected cells, 
and others. Although it is essential for normal development and health, an aberrant 
activation contributes to the pathogenesis of ischemic or neurodegenerative diseases and 
other processes (Walker et al., 1988). On the contrary, the apoptosis failure is a key factor in 
the pathogenesis of cancer or autoimmune disorders (Wyllie 1974). Apoptosis, is caused by 
the production of an endonuclease that destroys the DNA and induces cell phagocytosis by 
the neighboring elements, but without stimulating inflammation (Birge & Ucker 2008). In 
this context, visual impairment and blindness in glaucoma patients is attributed to the 
retinal ganglion cell damage and death (McKinnon, 1997).  
Apoptosis is a genetically coded cell suicide program that activates when any cell has been 
profoundly damaged or the cell is no longer needed. Microscopic findings of apoptotic cells 
include: 1) cytoplasmic organelles compaction, 2) nuclear chromatin condensation, and 3) 
membrane blebbing (Meagher et al., 1992).  
Furthermore, neurotrophin withdrawal and cytotoxic neurotransmitters release have also 
been involved in ganglion cell and optic fibers damage and death by apoptosis, in glaucoma 
(Carmignoto et al., 1997). Among the neurotrophic factors the BDNF is a pivotal molecule 
for neuron survival, in the developing and mature visual system (Snider 1994; Carmignoto 
et al., 1997). The BDNF was investigated in rats and monkeys regarding the retinal ganglion 
cells neurotrophin transport in experimental glaucoma, by using acute and chronic IOP 
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elevation and immunohistochemical assays with antibodies directed against the tyrosine 
kinase receptors (TrkA, B, C) and against BDNF, as well as by autoradiography to identify 
retrograde axonal transport of 125I-BDNF injected into the superior colliculus. The authors 
concluded that the interruption of BDNF retrograde transport and the accumulation of TrkB 
at the optic nervehead in acute/chronic glaucoma models strongly suggest a role for 
neurotrophin deprivation in the pathogenesis of glaucomatous ganglion cell death (Pease et 
al., 2000). 
Recently it has been stressed the importance of identifying molecular biomarkers or 
inducers of apoptosis for better glaucoma managing (Golubnitschaja & Flammer, 2007; 
Zanón-Moreno & Pinazo-Durán, 2008). Therefore, different classes of molecular anomalies 
can be detected and utilized for glaucoma progression, among them specific molecules 
closely related to cell survival and apoptosis, as follows. 
Caspase-3 is one of the cysteine proteases family that plays a role in apoptosis by cleaving a 
high variety of key proteins such as the poly (ADP-ribose) polymerase 1 (PARP-1), protein 
kinase C (PKC), DNA-dependent protein kinase, DNA-fragmentation factor (DFF) and 
others (see the drawn schematic on figure 3). Zang and Bhavnani (2005) described that up-
regulation of caspase-3 expression preceded neuronal cell death, supporting the possibility 
that glutamate-induced apoptotic cell death was the consequence of up-regulation of 
caspase-3 gene in cortical neurons. These observations are consistent with up-regulation of 
precursor caspase-3 in frontal neuronal cortex of subjects with Alzheimer's disease. This 
enzyme has been proposed to activate death effector molecules resulting in the fragmentation 
of genomic DNA and was associated with morphological and structural changes characteristic 
of apoptosis. 
Poly-Adenil Ribose Polymerase 1 (PARP1) is a reversible post-translational protein 
modification that is involved in the regulation of several biological functions. Whereas an 18 
member superfamily of PARP enzymes synthesize poly (ADP-ribose) (PAR), a single 
protein, PAR glycohydrolase (PARG) is responsible for the catabolism of the polymer. 
PARP-1 accounts for more than 90% of the poly (ADP-ribosyl)ating capacity of the cells 
(Viraq 2005). PARP-1 activated by DNA breaks cleaves NAD(+) into nicotinamide and ADP-
ribose, and uses it to synthesize long branching PAR polymers covalently attached to 
acceptor proteins including histones, DNA repair enzymes, transcription factors and PARP-
1 (Aguilar-Quesada et al., 2007). Activation of PARP-1 by mild genotoxic stimuli may 
facilitate DNA repair and cell survival. However irreparable DNA damage triggers 
apoptotic or necrotic cell death (as reflected in figure 3). In apoptosis, early PARP activation 
may assist the apoptotic cascade, by stabilizing p53, by mediating the translocation of 
apoptosis inducing factor (AIF) from the mitochondria to the nucleus or by inhibiting early 
activation of DNases. In most severe oxidative stress situations, excessive DNA damage 
causes over activation of PARP-1, which blocks the apoptotic elements and switches the 
mode of cell death from apoptosis to necrosis. In addition to serving as a cytotoxic mediator, 
PARP-1 is also implicated in transcriptional regulation processes, most notably in the NF 
kappaB and AP-1 driven expression of inflammatory mediators (Viraq 2005). In the case of 
pharmacological blockage or genetic inhibition of PARP-1 provided remarkable protection 
from tissue injury in various oxidative stress-related disease models ranging from 
endothelial dysfunction, myocardial ischaemia-reperfusion, stroke, shock, diabetes mellitus, 
Parkinson's disease, arthritis, and uveitis. These beneficial effects are attributed to inhibition 
of the PARP-1 mediated suicidal pathway and to reduced expression of inflammatory 
cytokines and other molecules (Quiles-Perez et al., 2010). 
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Despite former glaucoma statements, it has been suggested that within the retina, other cell 
phenotypes that the ganglion cells may be implicated. There is also increasing evidence that 
neuronal changes occur both in retina and central visual pathways in glaucoma and other 
neurodegenerative diseases. Axonal projections can be distinguished from dendrites by the 
shape, length and function. Dendrites are fine neuronal processes which support postsynaptic 
contact elements and are responsible for receiving synaptic signals. The morphological and 
functional integrity of dendrites has important effects on integrating neuronal input to the 
CNS from the peripheral targets. Axonal and dendritic changes have been detected in 
neurodegenerative processes, including those occurring in development, ageing and diseases. 
Therefore, axonal and dendritic pathology are early signs in disease and providing new 
insights into therapeutic strategies. Increased latency and reduced amplitude of visual evoked 
potentials, frequently encountered in ocular hypertension or POAG, suggest slowed neural 
conduction in the visual pathways (Parisi 1997; Bach and Hoffmann 2008). Recent research 
in monkeys demonstrated that the glaucomatous damage extends from the retina to the 
visual centers in the brain, but being the primary region of damage the optic nervehead, 
with the lateral geniculate nucleus being secondarily affected. These findings indicate that in 
Japanese monkeys, damage to neurons in the geniculate can be detected in a very early 
phase (first weeks) after an IOP elevation occurs, as can damage to optic nervehead (Itoa et 
al., 2009). By utilizing neuroimaging techniques such as diffusion tensor magnetic resonance 
imaging, functional magnetic resonance imaging, and magnetic resonance spectroscopy it 
has been evaluated the microstructural integrity of white-matter fibers and the functional 
activity of gray matter. They have been widely employed to investigate various diseases of 
the central nervous system, as glaucoma. It has been demonstrated alterations involving the 
human visual cortex that are consistent with clinically documented losses of visual function. 
These data support the use of imaging techniques as reliable, noninvasive tools for 
monitoring the progression of human glaucoma (Garacci et al., 2008) 
In this context, there may be new opportunities to develop treatments directed at the retina 
and the brain, such as those that promote healthy ocular tissues, the neurotrophic factors. 
Neurotrophic factors includes: 1) neurotrophins (NGF, BDNF, NT-3, NT-4), 2) neurokines 
(CNTF), and glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) 
(Bespalov and Saarma, 2007). Neurotrophic factors and their receptors regulate the 
development and physiology of neurons, but their roles in the CNS are far from complete. 
Among the neurotrophins, the brain derived neurotrophic factor (BDNF) (Snider 1994; 
Osborne et al., 1999; Harada et al., 2011) may help retinal ganglion cells to survive 
themselves; may increase axon outgrowth in the optic nerve, and may improve the 
environment in which the dying retinal ganglion cells and the surrounding elements are 
placed within the retina, optic nerve and visual pathway. 
Considering that the cell surviving and death mechanisms play a pivotal role in glaucoma 
progression, we propose that the p53 gene, as the outstanding cell cycle regulator, can be 
involved in the pathogenic processes of glaucoma in the retina and optic nerve. Therefore, 
we deal with examining the events that take place in the retina at the molecular level, after 
overexpressing p53 gene, with the inhibition of the cell cycle progression and the induction 
of the apoptosis-related pathway.  
2. The super p53 mice 
The C57BL6 strain is the most commonly used for genetic manipulation and biomedical 
research. Transgenic mice of the Charles River C57BL6/J strain were generated by addition 
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of two extra copies of p53 gene (García-Cao et al., 2002; Effeyan et al., 2006). Our main 
purpose is to characterize molecules involved in cell surviving and death in mice retina-
choroid.  
2.1 Animal and tissue handling  
All procedures were performed to minimize animal suffering in accordance with the 
European Community guidelines for the use of animals in research (609/1986). The Research 
Committee and Animal Research Committee of the participating centers approved the 
study. Mice were sacrificed and utilized by several investigators in our working area. For 
the purposes of the present study we utilized 24 mice that were distributed into two groups 
1) super p53 (sp53; n=12) and wild type (CG; n=12).  
Eyes with the retrobulbar optic nerves were microsurgically dissected, in a Nikon SM2 1500 
microscope. Briefly, after performing an “ab externo” enucleation, the eyes were washed in 
bidistilled water and placed on a Petri dish to be immobilized by means of a Barraquer 
forceps to perform an anterior segment paracentesis with a micro sharp blade angled 15º. By 
using the Vannas scissors a complete peritomy was performed, to separate the cornea and 
lens from the posterior eyecup (with the optic nerve attached), as previously described 
(Pinazo-Durán et al., 1993, 1997, 2005, 2011). The retina-choroid was obtained, and frozen 
and stored at -80º until processing. Homogenates of the retina-choroid were used to perform 
two main techniques: 
 
 
Fig. 5. The super p53 mice brain, eyeballs and optic nerves 
1) Enzyme-Linked ImmunoSorbent Assay (ELISA) for determining the BDNF levels in the 
ocular tissues, and 2) Western blot and immunoblotting procedures by determining the total 
protein concentration in the eye tissues, and SDS Page with transferring to nitrocellulose 
membranes, incubating alternatively with anti PARP1 and anti CS3 antibodies, as 
previously described by Laemmli (1970) and with some respectful modifications for the eye 
tissue processing by Pinazo-Durán et al., (1996). The expression bands of both molecules 
were alternatively examined and quantified by laser densitometry.  
www.intechopen.com
 
Glaucoma Genetics – Regulation of Cell Surviving and Death in the Retina   
 
217 
2.2 Expression of the BDNF, PARP1 and CS3 in the sp53 retina-choroid 
The ELISA assay allowed us to detect the BDNF concentration in the retina-choroid of both 
groups of mice. It was observed that the BDNF expression was significantly higher in the 
sp53 tissues than in the corresponding controls, as reflected in the Table 1. 
 
Molecules Sp53G WTG p-value 
BDNF (pg/mL) 121,13 ± 2,72 108,16 ± 4,43 0,00250 
PARP-1 (laser rdu) 143,28 ± 5,38 105,46 ± 3,91 0,00003 
CS-3 (laser rdu) 169,20 ± 3,17 167,22 ± 1,40 0,29600 
Table 1. 
 
 
 PARP-1 (banda 85kDa) en la retina de ratón (udr)
0
20
40
60
80
100
120
140
160
Sp53
WT
PARP1 Expression in mice retina-choroid  
(relative densitometric units) 
PARP-1
M
 
1 2 3 4 1 2 3 4 
Sp53
 
WT
 
85 kDa
 
 
Fig. 6. Immunobloting in mice retina choroid for PARP1 expression and the corresponding 
quantitative results by laser spectrometry 
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Fig. 7. 
The results showed that the two enzymes involved in the apoptotic cascade, PARP1 and CS 
3 expressed differently in the retina-choroid of the two groups of mice, depending on the 
genetic background. When the nitrocellulose membranes were incubated, revealed and 
examined, the corresponding bands of the PARP1 and CS3 expression were more noticeable 
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in the sp53G than in the wtG eyes, data confirmed by the quantification analysis performed 
by laser densitometry (relative densitometric units), as can also be observed in the above 
table 1. CS3, although there was more noticeable in mouse tissue samples sp53, showed no 
significant differences with the wild mouse having normal p53 genetic load (figures 6 and 7). 
3. Cell surviving and death  
As mentioned previously, several mechanisms have been implicated in initiating the 
apoptotic cascade in glaucoma. These mechanisms and their potential therapeutic effects 
include inflammation, ischaemia, excitotoxicity, oxidative stress, mitochondrial dysfunction, 
and neurotrophin deprivation. Taking into consideration that apoptosis significantly 
contributes to ganglion cell loss in glaucoma, and in the case that the specific apoptosis 
signalling pathways for glaucoma can be known (Ray & Mookherjee 2009), any agent that 
can help to block or interrupt the specific signalling, may have the potential to slowing or 
stopping glaucoma progression and visual loss. 
Charles et al., (2005) investigated the apoptosis-related signaling pathways in a cultured rat 
retinal ganglion cell (RGC-5) line deprived of growth factors after serum withdrawal from 
the culture medium. The authors described that serum withdrawal induces apoptotic cell 
death in RGC-5 cells, via mitochondrial pathways, leading to the speculation that growth 
factor deprivation arising from blockade of retrograde transport of neurotrophins, may 
involve similar mechanisms of retinal ganglion cell death in glaucoma. Khalyfa et al., (2007) 
induced apoptosis in the retinal ganglion cells in transformed rats in order to generate a 
genome-wide gene expression in cultures of retinal ganglion cells, following serum 
deprivation and to identify candidate genes that may be involved in the signal transduction 
pathways.  
Thus, the genes identified in microarray data and validated by real-time RT-PCR may play 
an important role in retinal ganglion cell death. Among the validated genes, C3 and C1s 
showed significant upregulation of the complement component pathway. The results further 
indicate that components of the complement pathway are present in neurons of the rat retina. 
It would be appropriate also in the context to cite that Erythropoietin modulates 
erythropoiesis by inhibiting apoptosis in erythrocyte progenitors. This molecule has been 
demonstrated to be protective in experimental models of trauma, cerebral and retinal 
ischaemia and neuroinflammation. Moreover, it was described that erythropoietin 
promoted retinal ganglion cell survival, without affecting IOP, in DBA/2J glaucomatous 
mice, suggesting that erythropoietin may be a potential therapeutic neuroprotectant in 
glaucoma (Zhong et al. 2007). 
It may be speculated that determining the regulation of cell survival and death mechanisms 
in the retina it may be throw some light on the pathogenesis of POAG. In this context, the 
elevated IOP leads to molecular events that are destructive to the retinal ganglion cells and 
optic axons, but also induces specific changes that are potentially protective against cellular 
injury and death. If this is the case, then the glaucomatous retinal ganglion cell death and 
subsequent axonal loss would result not only from initiation of apoptosis, but also from 
failure of intrinsic cell protective mechanisms.  
Consequently, it should therefore be theoretically probable to act on the regulation 
processes of these two classes of responses, and improving ganglion cells survival when 
glaucoma develops, as well as in glaucoma progression. Since the transgenic mouse used in 
the present work, which has 4 copies of the p53 gene, displayed a significantly higher 
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expression of molecules involved in cell surviving and death in the retina, we suggest that 
p53 may be involved in regulation of these processes. Our findings may open new 
diagnostic and therapeutic possibilities by the p53 related biomedical and biotechnological 
applications in glaucoma. 
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